Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10609 | 1049 | 30.9 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
128 | 2 | BONE MARROW TRANSPLANTATION//HEMATOLOGY//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 23958 |
10609 | 1 | VENO OCCLUSIVE DISEASE//DEFIBROTIDE//HEPATIC VENO OCCLUSIVE DISEASE | 1049 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VENO OCCLUSIVE DISEASE | authKW | 2620553 | 15% | 59% | 153 |
2 | DEFIBROTIDE | authKW | 2320916 | 9% | 82% | 97 |
3 | HEPATIC VENO OCCLUSIVE DISEASE | authKW | 691727 | 4% | 61% | 39 |
4 | SINUSOIDAL OBSTRUCTION SYNDROME | authKW | 562366 | 4% | 47% | 41 |
5 | VOD | authKW | 166862 | 2% | 23% | 25 |
6 | VENO OCCLUSIVE DISEASE OF THE LIVER | authKW | 130981 | 1% | 75% | 6 |
7 | SPANISH BONE MARROW DONOR PROGRAM | address | 116430 | 0% | 100% | 4 |
8 | HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME | authKW | 116426 | 1% | 67% | 6 |
9 | HEPATIC VOD | authKW | 116426 | 1% | 67% | 6 |
10 | SINUSOIDAL OBSTRUCTIVE SYNDROME | authKW | 109573 | 1% | 47% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 18360 | 40% | 0% | 423 |
2 | Transplantation | 15106 | 25% | 0% | 263 |
3 | Oncology | 2247 | 25% | 0% | 264 |
4 | Immunology | 1932 | 22% | 0% | 228 |
5 | Gastroenterology & Hepatology | 1022 | 10% | 0% | 106 |
6 | Peripheral Vascular Diseases | 692 | 8% | 0% | 86 |
7 | Pediatrics | 373 | 7% | 0% | 78 |
8 | Surgery | 233 | 10% | 0% | 106 |
9 | Pharmacology & Pharmacy | 195 | 10% | 0% | 110 |
10 | Pathology | 144 | 4% | 0% | 42 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SPANISH BONE MARROW DONOR PROGRAM | 116430 | 0% | 100% | 4 |
2 | HEMATOL ONCOL ADULT ONCOL | 87322 | 0% | 100% | 3 |
3 | BUD EST INTERNAL MED 3 | 58215 | 0% | 100% | 2 |
4 | STEM CELL TRANSPLANTAT UNITHEMATOL | 58215 | 0% | 100% | 2 |
5 | MED GENOME CLIN PLICAT | 38809 | 0% | 67% | 2 |
6 | STEM CELL TRANSPLANT UNIT ADULTS | 38809 | 0% | 67% | 2 |
7 | GASTROENTEROL HEPATOL SECT D2 190 | 38805 | 0% | 33% | 4 |
8 | 1109 W LAVETA AVE | 29107 | 0% | 100% | 1 |
9 | ABT HAMATOL INTERIST ONKOL | 29107 | 0% | 100% | 1 |
10 | ADULT PEDIAT ONCOL | 29107 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE MARROW TRANSPLANTATION | 55141 | 12% | 1% | 129 |
2 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 9879 | 3% | 1% | 30 |
3 | HAEMOSTASIS | 7601 | 2% | 1% | 18 |
4 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 6438 | 2% | 1% | 26 |
5 | CLINICAL ONCOLOGY-US | 2909 | 0% | 10% | 1 |
6 | THROMBOSIS RESEARCH | 2867 | 3% | 0% | 32 |
7 | LIVER | 2069 | 1% | 1% | 9 |
8 | TRANSPLANTATION | 1999 | 3% | 0% | 36 |
9 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 1416 | 1% | 0% | 10 |
10 | PEDIATRIC TRANSPLANTATION | 1253 | 1% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DIGNAN, FL , WYNN, RF , HADZIC, N , KARANI, J , QUAGLIA, A , PAGLIUCA, A , VEYS, P , POTTER, MN , (2013) BCSH/BSBMT GUIDELINE: DIAGNOSIS AND MANAGEMENT OF VENO-OCCLUSIVE DISEASE (SINUSOIDAL OBSTRUCTION SYNDROME) FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 163. ISSUE 4. P. 444 -457 | 80 | 91% | 38 |
2 | CARRERAS, E , (2015) HOW I MANAGE SINUSOIDAL OBSTRUCTION SYNDROME AFTER HAEMATOPOIETIC CELL TRANSPLANTATION.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 168. ISSUE 4. P. 481 -491 | 65 | 88% | 21 |
3 | HELMY, A , (2006) REVIEW ARTICLE: UPDATES IN THE PATHOGENESIS AND THERAPY OF HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 23. ISSUE 1. P. 11-25 | 113 | 76% | 52 |
4 | DELEVE, LD , SHULMAN, HM , MCDONALD, GB , (2002) TOXIC INJURY TO HEPATIC SINUSOIDS: SINUSOIDAL OBSTRUCTION SYNDROME (VENO-OCCLUSIVE DISEASE).SEMINARS IN LIVER DISEASE. VOL. 22. ISSUE 1. P. 27 -41 | 99 | 71% | 256 |
5 | RICHARDSON, P , LINDEN, E , REVTA, C , HO, V , (2009) USE OF DEFIBROTIDE IN THE TREATMENT AND PREVENTION OF VENO-OCCLUSIVE DISEASE.EXPERT REVIEW OF HEMATOLOGY. VOL. 2. ISSUE 4. P. 365-376 | 83 | 82% | 7 |
6 | DALLE, JH , GIRALT, SA , (2016) HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: RISK FACTORS AND STRATIFICATION, PROPHYLAXIS, AND TREATMENT.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 22. ISSUE 3. P. 400 -409 | 56 | 82% | 3 |
7 | KUMAR, S , DELEVE, LD , KAMATH, PS , TEFFERI, A , (2003) HEPATIC VENO-OCCLUSIVE DISEASE (SINUSOIDAL OBSTRUCTION SYNDROME) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.MAYO CLINIC PROCEEDINGS. VOL. 78. ISSUE 5. P. 589-598 | 84 | 83% | 76 |
8 | HO, VT , LINDEN, E , REVTA, C , RICHARDSON, PG , (2007) HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STERN CELL TRANSPLANTATION: REVIEW AND UPDATE ON THE USE OF DEFIBROTIDE.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 33. ISSUE 4. P. 373-388 | 91 | 72% | 27 |
9 | KEATING, GM , (2014) DEFIBROTIDE: A REVIEW OF ITS USE IN SEVERE HEPATIC VENO-OCCLUSIVE DISEASE FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION.CLINICAL DRUG INVESTIGATION. VOL. 34. ISSUE 12. P. 895 -904 | 56 | 98% | 4 |
10 | RICHARDSON, PG , KRISHNAN, A , GIRALT, S , SOIFFER, RJ , (2015) DEFIBROTIDE FOR THE TREATMENT OF SEVERE HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME: EVIDENCE FOR CLINICAL BENEFIT.EXPERT OPINION ON ORPHAN DRUGS. VOL. 3. ISSUE 12. P. 1491 -1501 | 54 | 96% | 0 |
Classes with closest relation at Level 1 |